Science
Mechanism of Action
This chromanol is hypothesized to exert its beneficial effects through several key pathways. As a strong antioxidant, it targets and reduces intracellular reactive oxygen species (ROS) production induced by UVA radiation, consequently minimizing membrane protein oxidation and lipid peroxidation. Its anti-aging action involves the inhibition of matrix metalloproteinases (MMP-1, -2, -9), which are crucial enzymes in collagen degradation, alongside an increase in the expression of tissue inhibitors of metalloproteinases (TIMP-1, -2). Furthermore, it is expected to modulate UVA-enhanced transcriptional activation of the AP-1 signaling pathway, a known contributor to photoaging. In terms of anti-inflammatory capabilities, related sargachromanols have been shown to suppress NF-κB activation and MAPK phosphorylation, pathways central to inflammation, leading to a reduction in pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6, and inflammatory mediators such as nitric oxide, iNOS, prostaglandin E2, and COX-2.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Studies on Sargachromanol G, a related compound, demonstrated dose-dependent inhibition of inflammatory markers (nitric oxide, iNOS, PGE2, COX-2) and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) at concentrations of 10 µM, 20 µM, and 40 µM in LPS-stimulated RAW 264.7 cells.
- 02 Sargachromanol E, another related chromanol, was shown to inhibit ultraviolet A (UVA)-induced skin aging in human dermal fibroblasts. Its effects included suppressing intracellular ROS production, membrane protein oxidation, lipid peroxidation, and the expression of collagenases (MMP-1, MMP-2, MMP-9) induced by UVA. These benefits were associated with an upregulation of TIMP-1 and TIMP-2 genes and an inhibition of UVA-induced AP-1 signaling activation.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Sargachromanol F is highly lipophilic with a computed LogP of 6.9. Based on recommendations for Sargachromanol E, it is likely sensitive to degradation, particularly in solution or at elevated temperatures. Optimal storage for the powder form of related chromanols is at -20°C for up to 3 years, and in solvent at -80°C for up to 1 year, suggesting similar stability precautions may be necessary for Sargachromanol F.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel, in a 2019 assessment, identified Sargachromanol F as a brown algae-derived ingredient for which there was insufficient data to determine a conclusion of safety.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While related sargachromanols show promising antioxidant, anti-inflammatory, and anti-aging properties, direct clinical efficacy and comprehensive safety data for Sargachromanol F are currently insufficient for a definitive assessment.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources